Article
Investigation of BRAF V600E detection approaches in papillary thyroid carcinoma.
Pathology, research and practice - 1 Feb 2018
Chen Dan, Qi Wenjing, Zhang Pengxin, Zhang Yunkun, Liu Ye, Guan Hongwei, Wang Lifen
Abstract excerpt
OBJECTIVE: The detection of BRAF V600E mutation in papillary thyroid carcinoma (PTC) may be helpful to offer diagnostic confirmation. Additionally, such detection may provide a targeted therapeutic approach for the radioactive iodine resistant patients to predict adverse outcomes. To compare the results of immunohistochemistry (IHC) method using the anti-BRAF V600E (VE1) antibody with the Quantitative real-time...
Topics
- Carcinoma, Papillary
- DNA, Neoplasm
- Humans
- Immunohistochemistry
- Mutation
- Neoplasm Metastasis
- Proto-Oncogene Proteins B-raf
- Thyroid Cancer, Papillary
- Thyroid Neoplasms
